Let Canada’s #1 pharmacology text guide you in mastering the complicated world of nursing pharmacology! Now in its fifth edition, Lilley’s Pharmacology for Canadian Health Care Practice covers all the key pharmacology content needed by today’s Canadian nurses. Known for its vibrant design, abundance of visuals, and wealth of helpful feature boxes, this engaging text brings important pharmacology concepts to life. The book’s popular and unique key drug approach focuses on the drug information you need to know to safely and effectively administer drugs. Providing exam preparation and insightful learning strategies, this complete (and proven) pharmacology text helps you succeed in school, clinicals, and professional practice.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Inside front cover - p. iii 6. How to use - p. iii 7. Table of contents - p. iii 8. Copyright - p. iii 9. About the authors - p. iv 10. Reviewers - p. ix 11. Preface - p. xi 12. Acknowledgements - p. xv 13. Contents - p. xv 14. PART 1: Pharmacology Basics - p. p1 15. 1. Nursing practice in Canada and drug therapy - p. p1 16. 2. Pharmacological principles - p. 12 17. 3. Legal and ethical considerations - p. 34 18. 4. Patient-focused considerations - p. 46 19. 5. Gene therapy and pharmacogenomics - p. 63 20. 6. Medication errors: Preventing and responding - p. 70 21. 7. Patient education and drug therapy - p. 83 22. 8. Over-the-counter drugs and natural health products - p. 94 23. 9. Vitamins and minerals - p. 106 24. 10. Principles of drug administration - p. 127 25. PART 2: Drugs Affecting the Central Nervous System - p. p159 26. 11. Analgesic drugs - p. p159 27. 12. General and local anaesthetics - p. 190 28. 13. Central nervous system depressants and muscle relaxants - p. 208 29. 14. Central nervous system stimulants and related drugs - p. 223 30. 15. Antiepileptic drugs - p. 239 31. 16. Antiparkinsonian drugs - p. 256 32. 17. Psychotherapeutic drugs - p. 272 33. 18. Substance use disorder - p. 302 34. PART 3: Drugs Affecting the Autonomic Nervous System - p. p321 35. 19. Adrenergic drugs - p. 321 36. 20. Adrenergic-blocking drugs - p. 334 37. 21. Cholinergic drugs - p. 345 38. 22. Cholinergic-blocking drugs - p. 357 39. PART 4: Drugs Affecting the Cardiovascular and Renal System - p. p367 40. 23. Antihypertensive drugs - p. p367 41. 24. Antianginal drugs - p. 391 42. 25. Heart failure drugs - p. 404 43. 26. Diuretic drugs - p. 421 44. 27. Antidysrhythmic drugs - p. 434 45. 28. Coagulation modifier drugs - p. 457 46. 29. Antilipemic drugs - p. 481 47. 30. Fluids and electrolytes - p. 497 48. PART 5: Drugs Affecting the Endocrine System - p. p517 49. 31. Pituitary drugs - p. 517 50. 32. Thyroid and antithyroid drugs - p. 526 51. 33. Antidiabetic drugs - p. 534 52. 34. Adrenal drugs - p. 562 53. 35. Women’s health drugs - p. 573 54. 36. Men’s health drugs - p. 597 55. PART 6: Drugs Affecting the Respiratory System - p. p607 56. 37. Antihistamines, decongestants, antitussives, and expectorants - p. p607 57. 38. Respiratory drugs - p. 621 58. PART 7: Drugs Affecting the Gastrointestinal System and Nutrition - p. p643 59. 39. Acid-controlling drugs - p. p643 60. 40. Antidiarrheal drugs and laxatives - p. 657 61. 41. Antiemetic and antinausea drugs - p. 671 62. 42. Nutritional supplements - p. 681 63. PART 8: Anti-Infective and Anti-Inflammatory Drugs - p. p695 64. 43. Antibiotics part 1: Sulfonamides, penicillins, cephalosporins, macrolides, and tetracyclines - p. 695 65. 44. Antibiotics part 2: Aminoglycosides, fluoroquinolones, and other drugs - p. 718 66. 45. Antiviral drugs - p. 735 67. 46. Antitubercular drugs - p. 757 68. 47. Antifungal drugs - p. 769 69. 48. Antimalarial, antiprotozoal, and anthelmintic drugs - p. 779 70. 49. Anti-inflammatory and antigout drugs - p. 793 71. PART 9: Immune and Biological Modifiers and Chemotherapeutic Drugs - p. p809 72. 50. Immunosuppressant drugs - p. 809 73. 51. Immunizing drugs and pandemic preparedness - p. 819 74. 52. Antineoplastic drugs part 1: Cancer overview and cell cycle–specific drugs - p. 836 75. 53. Antineoplastic drugs part 2: Cell cycle–nonspecific and miscellaneous drugs - p. 863 76. 54. Biological response–modifying drugs and antirheumatic drugs - p. 876 77. PART 10: Miscellaneous Therapeutics: Hematological, Ophthalmic, and Otic Drugs - p. p897 78. 55. Anemia drugs - p. 897 79. 56. Dermatological drugs - p. 908 80. 57. Ophthalmic drugs - p. 923 81. 58. Otic drugs - p. 944 82. APPENDIX A. Pharmaceutical abbreviations - p. 950 83. APPENDIX B. Laboratory reference values - p. 951 84. Answers to review questions - p. 954 85. Index of glossary terms - p. 956 86. Drug index - p. 961 87. General index - p. 968 88. Special features - p. 1009
Let Canada’s #1 pharmacology text guide you in mastering the complicated world of nursing pharmacology! Now in its fifth edition, Lilley’s Pharmacology for Canadian Health Care Practice covers all the key pharmacology content needed by today’s Canadian nurses. Known for its vibrant design, abundance of visuals, and wealth of helpful feature boxes, this engaging text brings important pharmacology concepts to life. The book’s popular and unique key drug approach focuses on the drug information you need to know to safely and effectively administer drugs. Providing exam preparation and insightful learning strategies, this complete (and proven) pharmacology text helps you succeed in school, clinicals, and professional practice.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Inside front cover - p. iii 6. How to use - p. iii 7. Table of contents - p. iii 8. Copyright - p. iii 9. About the authors - p. iv 10. Reviewers - p. ix 11. Preface - p. xi 12. Acknowledgements - p. xv 13. Contents - p. xv 14. PART 1: Pharmacology Basics - p. p1 15. 1. Nursing practice in Canada and drug therapy - p. p1 16. 2. Pharmacological principles - p. 12 17. 3. Legal and ethical considerations - p. 34 18. 4. Patient-focused considerations - p. 46 19. 5. Gene therapy and pharmacogenomics - p. 63 20. 6. Medication errors: Preventing and responding - p. 70 21. 7. Patient education and drug therapy - p. 83 22. 8. Over-the-counter drugs and natural health products - p. 94 23. 9. Vitamins and minerals - p. 106 24. 10. Principles of drug administration - p. 127 25. PART 2: Drugs Affecting the Central Nervous System - p. p159 26. 11. Analgesic drugs - p. p159 27. 12. General and local anaesthetics - p. 190 28. 13. Central nervous system depressants and muscle relaxants - p. 208 29. 14. Central nervous system stimulants and related drugs - p. 223 30. 15. Antiepileptic drugs - p. 239 31. 16. Antiparkinsonian drugs - p. 256 32. 17. Psychotherapeutic drugs - p. 272 33. 18. Substance use disorder - p. 302 34. PART 3: Drugs Affecting the Autonomic Nervous System - p. p321 35. 19. Adrenergic drugs - p. 321 36. 20. Adrenergic-blocking drugs - p. 334 37. 21. Cholinergic drugs - p. 345 38. 22. Cholinergic-blocking drugs - p. 357 39. PART 4: Drugs Affecting the Cardiovascular and Renal System - p. p367 40. 23. Antihypertensive drugs - p. p367 41. 24. Antianginal drugs - p. 391 42. 25. Heart failure drugs - p. 404 43. 26. Diuretic drugs - p. 421 44. 27. Antidysrhythmic drugs - p. 434 45. 28. Coagulation modifier drugs - p. 457 46. 29. Antilipemic drugs - p. 481 47. 30. Fluids and electrolytes - p. 497 48. PART 5: Drugs Affecting the Endocrine System - p. p517 49. 31. Pituitary drugs - p. 517 50. 32. Thyroid and antithyroid drugs - p. 526 51. 33. Antidiabetic drugs - p. 534 52. 34. Adrenal drugs - p. 562 53. 35. Women’s health drugs - p. 573 54. 36. Men’s health drugs - p. 597 55. PART 6: Drugs Affecting the Respiratory System - p. p607 56. 37. Antihistamines, decongestants, antitussives, and expectorants - p. p607 57. 38. Respiratory drugs - p. 621 58. PART 7: Drugs Affecting the Gastrointestinal System and Nutrition - p. p643 59. 39. Acid-controlling drugs - p. p643 60. 40. Antidiarrheal drugs and laxatives - p. 657 61. 41. Antiemetic and antinausea drugs - p. 671 62. 42. Nutritional supplements - p. 681 63. PART 8: Anti-Infective and Anti-Inflammatory Drugs - p. p695 64. 43. Antibiotics part 1: Sulfonamides, penicillins, cephalosporins, macrolides, and tetracyclines - p. 695 65. 44. Antibiotics part 2: Aminoglycosides, fluoroquinolones, and other drugs - p. 718 66. 45. Antiviral drugs - p. 735 67. 46. Antitubercular drugs - p. 757 68. 47. Antifungal drugs - p. 769 69. 48. Antimalarial, antiprotozoal, and anthelmintic drugs - p. 779 70. 49. Anti-inflammatory and antigout drugs - p. 793 71. PART 9: Immune and Biological Modifiers and Chemotherapeutic Drugs - p. p809 72. 50. Immunosuppressant drugs - p. 809 73. 51. Immunizing drugs and pandemic preparedness - p. 819 74. 52. Antineoplastic drugs part 1: Cancer overview and cell cycle–specific drugs - p. 836 75. 53. Antineoplastic drugs part 2: Cell cycle–nonspecific and miscellaneous drugs - p. 863 76. 54. Biological response–modifying drugs and antirheumatic drugs - p. 876 77. PART 10: Miscellaneous Therapeutics: Hematological, Ophthalmic, and Otic Drugs - p. p897 78. 55. Anemia drugs - p. 897 79. 56. Dermatological drugs - p. 908 80. 57. Ophthalmic drugs - p. 923 81. 58. Otic drugs - p. 944 82. APPENDIX A. Pharmaceutical abbreviations - p. 950 83. APPENDIX B. Laboratory reference values - p. 951 84. Answers to review questions - p. 954 85. Index of glossary terms - p. 956 86. Drug index - p. 961 87. General index - p. 968 88. Special features - p. 1009
